US20070209669A1 - Monitoring and quantification of smoking behaviors - Google Patents
Monitoring and quantification of smoking behaviors Download PDFInfo
- Publication number
- US20070209669A1 US20070209669A1 US11/682,601 US68260107A US2007209669A1 US 20070209669 A1 US20070209669 A1 US 20070209669A1 US 68260107 A US68260107 A US 68260107A US 2007209669 A1 US2007209669 A1 US 2007209669A1
- Authority
- US
- United States
- Prior art keywords
- puff
- data
- subject
- smoking
- morphology
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000000391 smoking effect Effects 0.000 title claims abstract description 65
- 238000012544 monitoring process Methods 0.000 title claims abstract description 32
- 230000006399 behavior Effects 0.000 title claims abstract description 31
- 238000011002 quantification Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 43
- 230000000694 effects Effects 0.000 claims description 19
- 230000003434 inspiratory effect Effects 0.000 claims description 8
- 238000012806 monitoring device Methods 0.000 claims description 7
- 230000000877 morphologic effect Effects 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 206010006322 Breath holding Diseases 0.000 description 26
- 239000000779 smoke Substances 0.000 description 19
- 210000004072 lung Anatomy 0.000 description 15
- 210000000038 chest Anatomy 0.000 description 12
- 230000000241 respiratory effect Effects 0.000 description 9
- 230000003187 abdominal effect Effects 0.000 description 8
- 230000002802 cardiorespiratory effect Effects 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 235000019504 cigarettes Nutrition 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 230000000747 cardiac effect Effects 0.000 description 4
- 230000002596 correlated effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000002685 pulmonary effect Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000007958 sleep Effects 0.000 description 4
- 208000019693 Lung disease Diseases 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000011664 signaling Effects 0.000 description 3
- 241000208125 Nicotiana Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 210000003123 bronchiole Anatomy 0.000 description 2
- 235000019506 cigar Nutrition 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000003860 sleep quality Effects 0.000 description 2
- 230000004622 sleep time Effects 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 206010057852 Nicotine dependence Diseases 0.000 description 1
- 208000025569 Tobacco Use disease Diseases 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 238000009954 braiding Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000001007 puffing effect Effects 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 230000036387 respiratory rate Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000004620 sleep latency Effects 0.000 description 1
- 230000008667 sleep stage Effects 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F47/00—Smokers' requisites not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/091—Measuring volume of inspired or expired gases, e.g. to determine lung capacity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/113—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb occurring during breathing
- A61B5/1135—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb occurring during breathing by monitoring thoracic expansion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6802—Sensor mounted on worn items
- A61B5/6804—Garments; Clothes
- A61B5/6805—Vests
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/333—Recording apparatus specially adapted therefor
- A61B5/335—Recording apparatus specially adapted therefor using integrated circuit memory devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/369—Electroencephalography [EEG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/398—Electrooculography [EOG], e.g. detecting nystagmus; Electroretinography [ERG]
Definitions
- the present invention is related to ambulatory physiological monitoring, and in particular to automatic systems and methods that quantify a subject's overall smoking behaviors over time and that quantify characteristics of the subject's method of smoking, e.g., the nature of the subject's puffs.
- Smoking whether of cigarettes, cigars, pipes, or other smoking materials, is well known as a serious health problem worldwide leading to significant morbidity and mortality primarily from induced lung disease. It is advantageous to provide smokers with facilities and information to aid them to cease smoking, or to limit smoking, or to smoke in less pathogenic ways. It is also advantageous to estimate the likelihood and severity of possible lung disease in dependence on a subject's smoking behavior. It is also advantageous to monitor and to quantify the average smoking behaviors of several subjects and/or of populations of subjects for public health, research, and other purposes.
- Objects of the present invention are to provide systems and computer-implemented methods that provide smokers with such information.
- This invention includes the use of an ambulatory cardio-respiratory monitoring system to provide data that can be processed and interpreted to monitor and quantify specific characteristics of a subject's cigarette and other types of smoking. This monitoring will enable a greater understanding of the interaction between smoker and cigarette, or other smoking material. It will also aid individual smokers to cease, limit, or improve their smoking behaviors.
- the invention provides methods to analyze ambulatory and/or clinical and/or laboratory monitoring data to characterize a subject's overall smoking behavior and details of the subject's smoking behavior, i.e., characteristics of the subject's individual puffs and overall puffing pattern, and how these behaviors very with different smoking materials. Overall smoking is determined in dependence on the number of puffs and on the times of their occurrence as revealed by the monitoring data.
- the invention identifies specific characteristics that indicate a breath is a puff, and further identifies important morphological characteristics of individual puffs.
- computer-implemented methods examine tidal volume (Vt) data for puff-indicating characteristics to identify puffs. Further, it is preferred that these computer-implemented methods also examine Vt data of each puff to identify important morphological characteristics. Puff occurrence data and puff morphology data are retained and statistically summarized in order to provide characterization of all aspects of a subject's smoking behavior, i.e., a subject's overall smoking behavior and details of how the subject puffs
- Single puffs can also be monitored and quantified by determining puff inspiratory and puff expiratory volume, flow, and timing. Additionally, effects of smoking on heart rate, heart rate variability, and activity can be correlated if cardiac data is also available. Further, smoking patterns and smoker interaction with their smoking implement can provide diagnostic information related to smoking addiction and prognostic information related to likelihood of development of smoking related diseases.
- complete ambulatory and/or clinical and/or laboratory monitoring data including cardiac, respiratory, and activity data enables detailed correlation of the activities/actions of smoker related to the inspiration, holding, and expiration of smoke and of the effect of smoking on subsequent respiratory pattern, blood oxygen saturation, heart-rate and heart rate variability, pre- and post-smoking physical activity level, and the like.
- Continuous monitoring during a day and night permits correlation of variations in smoking habits with respiratory pattern and subsequent sleep latency, sleep time and sleep quality.
- aspects of the invention include monitoring the ways in which smokers smoke cigarettes of different types, such a filtered, non-filtered, menthol, low-tar, etc, and with cigars, pipes and other smoking implements.
- Other aspects of the invention include use of monitoring data as bio-feedback information for smokers wishing to modify their smoking behaviors in order to wean themselves from the smoking related nicotine addiction.
- Other aspects of the invention include the use of smoking behavior data to estimate the likelihood and severity of smoking associated diseases with more accuracy than estimates based on “packs per day” smoked.
- Other aspects of the invention include collecting smoking behavior data from various subject populations and storing this data in databases for various public health, research, and other purposes.
- a preferred ambulatory monitoring system is capable of monitoring tidal volume, the relative contributions of rib cage and abdominal expansion to tidal volume, heart rate, ECG, motion, blood oxygen saturation, posture, and activity.
- Such systems are available from VivoMetrics, Inc., Ventura, Calif.
- FIG. 1 illustrates a 5 minute and 45 second smoking record
- FIG. 2 illustrates morphology of a first puff
- FIG. 3 illustrates morphology of a second puff
- FIG. 4 illustrates morphology of a third puff
- FIG. 5 illustrates morphology of a fourth puff
- FIGS. 6A-B illustrates a preferred ambulatory monitoring system and exemplary embodiments of the methods of this invention.
- This invention is useful for subjects that are monitored while ambulatory or that are monitored while in the clinic. This invention is further useful for laboratory monitoring and studies. Although, this invention may be described as “ambulatory”, or as “clinical”, or as laboratory” in this application, use of these words individually in not intended to limit the applicability of this invention.
- the act of smoking results in characteristic patterns of cardio-respiratory, ambulatory monitoring data.
- the present invention provides systems and computer-implemented methods to recognize and to quantify these characteristic patterns. These methods are now described with reference to FIG. 1-4 , which illustrate exemplary smoking patterns. Preferred ambulatory monitoring devices and data analysis systems are described subsequently.
- Methods of this invention can be broadly divided, first, into those that recognize puffs in cardio-respiratory data and then quantify a subject's overall smoking behavior over time (smoking behavior methods) in dependence on recognized puffs.
- a second group of methods are those that examine each puff in detail in order to quantify and classify the subject's manner of smoking (manner of smoking methods or puff morphology methods).
- FIG. 1 illustrates cardio-respiratory monitoring data from a subject during a 5 min. 45 sec period of smoking.
- the Vt trace is the subject's tidal volume; the RC and AB traces are expansions and contractions of the subject's rib cage and abdomen, respectively; the spikes on the trace labeled Br/M mark the beginning of each breath and the height of a spike indicates the volume of the associated breath; the height of spikes in the trace labeled Ve/Vol trace indicate the expiratory volume of the associated breath; the ECG trace is the concurrent electrocardiogram; the HR trace is the heart rate; and the ACC trace is accelerometer data reflecting subject activity. During this period, the subject puffed 14 times as indicated by the highlighted bands. These puffs have distinguishing characteristics, and the computer-implemented methods of the invention recognize occurrences of puffs by examining the record for these distinguishing characteristics.
- Puffs 11 illustrate the waveform characteristics and features signaling a puff.
- puffs typically have durations approximately 2.5 to 3.0 times longer than the durations of adjacent breaths, and amplitudes approximately 2 times greater than the amplitudes of adjacent breaths.
- puffs have a characteristic shape, again illustrated by puffs 11 .
- a puff is a single breath with a single inspiratory phase and a single expiratory phase.
- the slope of the expiratory phase is substantially constant or slowly varying (the relative change in slope being less than approximately 50%).
- the inspiratory phase often includes two segments of similar slope separated by an intervening period of low to zero but never negative. That is, exhalation does not occur in the intervening period.
- the slope of the inspiratory phase is also often substantially constant or slowly varying.
- the inspiratory and expiratory phases can be separated by breath-holding periods at substantially constant but elevated lung volume.
- one primary feature signaling a puff is a breath with a duration and amplitude both of which approximately 1.5 to 2.0 times longer or greater, respectively, than adjacent breaths. The greater these deviations, the greater is the confidence that the particular breath is a puff.
- a further primary signaling feature a substantially single inspiratory phase, which may be interrupted by a period at a substantially constant lung volume, and a substantially single expiratory phase. A breath holding period at a substantially constant, elevated lung volume may separate inhalation and exhalation.
- a puff characteristically has no further structure. In fact, further structure indicates the breath is not likely to be a puff, being instead, perhaps, a cough, or a sigh, or a period of speech, or the like.
- a secondary feature is heart rate which is usually decreasing over most of the puffs duration.
- a puff is preferably identified as a breath having a pre-determined combination of these primary and secondary features, presence of absence of features being determined by computer-implemented examination of monitoring data.
- Puffs are most reliably recognized during periods of limited subject activity, which can be indicated by a motion sensor, e.g., an accelerometer, that is part of the ambulatory monitoring apparatus.
- the ACC trace is an accelerometer trace indicating limited subject activity.
- puff identification can be suspended during such activity and the period of suspension noted in the data set.
- Sleep can be assessed by time spent in various sleep stages, the number of nocturnal arousals, and the like.
- sleep parameters and determined from cardio-respiratory and motion monitoring data See ⁇ non-eeg sleep>>> application included in its entirety herein by reference for all purposes.
- puff morphology is important in improving estimates of pulmonary exposure to tobacco smoke, which are initially provided by the smoking behavior methods.
- Different puff morphologies are known to result in lesser or greater smoke exposure. Shorter puffs, and puffs consisting of a single inspiration followed closely by a single expiration without noticeable breath holding, limit both smoke exposure time and location of smoke exposure in the pulmonary tree. In particular, such puffs result in reduced smoke and particulate exposure of the smaller bronchioles and alveoli. These pulmonary components are more sensitive to smoke-induced injury causing ultimately to emphysema and/or COPD.
- puffs and puffs with breath holding provide more time for distribution and diffusion of smoke and particulates in the respiratory tree, leading to increased smoke and particulate exposure of the smaller bronchioles and alveoli receive and to increased likelihood of their injury.
- a puff primarily due to rib cage expansion tends to lead to only limited smoke exposure in the peripheral airways.
- a puff with relatively equal expansion of the rib cage and the abdomen tends to cause increase smoke exposure in the peripheral airways. Since puff morphology affects airway smoke exposure, this morphology can provide prognostic information concerning the occurrence and severity of smoking related lung diseases.
- methods of the second class preferably recognize additional features in the tidal volume trace including, for one or more previously identified puffs: duration in seconds; presence or absence of a reduced-amplitude puff prior to the primary inhalation; relative importance of rib cage and abdominal motions in the puff; relative duration of inhalation and of exhalation; whether inhalation and exhalation are smooth or any interrupted with multiple phases; duration of breath holding if any; lung volume during breath holding; and the like.
- Total duration of a true puff is approximately the duration of any reduced prior puff, plus the duration of inhalation, plus the duration of any breath holding, and plus the duration of exhalation.
- FIGS. 2-4 illustrate puffs of various types which illustrate these waveform features.
- FIG. 2 illustrates a mono-phasic-type puff which is simply an inhalation followed by an exhalation without significant breath holding.
- This type of puff includes the following features: reduced initial puff 21 , followed by primary inhalation 23 and primary exhalation 25 . Both the inhalation and exhalation have slopes that are smoothly varying without evident phases or interruptions.
- This puff has no breath holding between inhalation and exhalation, and rib cage expansion 27 makes a significantly greater contribution to this puff than does abdominal expansion 29 .
- FIG. 3 illustrates a puff with a single breath holding phase but it otherwise generally similar to the puff of FIG. 2 .
- This puff includes the following features: reduced initial puff 41 ; inhalation 43 with smoothly varying slope; breath holding 45 after partial expiration; and exhalation 49 .
- the inhalation and exhalation have smoothly varying slopes with the lung volume at the end of exhalation lower than the lung volume at start of inhalation.
- Breath-holding-period duration is less than 50% of puff duration and includes a slow exhalation; it is therefore a less prominent breath holding.
- the height of indicator 49 is proportional to expiratory volume and time of expiration.
- the contribution of rib cage expansion 42 and abdominal expansion 44 are more comparable although rib cage expansion still dominates.
- FIG. 4 illustrates a puff with more prominent breath holding.
- breath holding 55 is more prominent: it extends for more than half the pulse duration; lung volume during breath holding is approximately at an end-inspiratory volume comparable to adjacent breaths; and the lung volume is substantially constant during breath holding.
- the contribution of rib cage expansion 52 is here only marginally greater than the contribution of abdominal expansion 54 .
- the height of indicator 59 represents a large expiration prior to inhalation.
- Inhalation 53 and exhalation 57 again have smoothly varying slopes with phases or interruptions.
- FIG. 5 illustrates very prominent breath holding at high lung volumes along with a biphasic inhalation.
- the inhalation displays an initial phase 71 followed by a breath holding interruption 73 at an approximately constant lung volume that is considerably higher than the end-inspiratory volume of adjacent breaths.
- Inhalation resumes 75 drawing more smoke into the lungs and distributing the already-present smoke further into the lung periphery.
- Following this inhalation phase is a further period of breath holding 77 at an even higher lung volume.
- These breath holding periods inhale a volume of smoke that is 2 to 3 times the tidal volume of adjacent normal breaths. This puff ends with smooth expiration 79 back to the lung volume and the beginning of inhalation.
- approximately equal rib cage 72 and abdominal 74 expansions are needed to inhale and hold this significant volume of smoke.
- a basic morphological classification of puffs preferably includes at least the duration and volume of the puff in comparison to adjacent normal breaths, and the relative duration of breath holding and the lung volume during breath holding, again in comparison to adjacent normal breaths.
- ambulatory monitoring and data analysis systems are now described which gather the data analyzed by the described smoking behavior and puff morphology methods.
- Physiological data can be gathered by a wide variety of monitoring systems designed for, e.g., in-hospital use, or in-clinic use, or ambulatory use, or other uses. Without limitation or prejudice, however, the following description is largely in terms of preferred monitoring systems for ambulatory use.
- physiological sensors are attached to, or affixed to, or carried by, or incorporated in or as part of ordinary wearable items that are unobtrusive, comfortable, and useable without assistance.
- Suitable wearable items include garments, jackets, bands, patches, and the like, made from a variety of materials, particularly elastic materials to insure a snug fit; they can be donned in one piece or include zippers, Velcro, snaps, and the like, that are joined after donning.
- Sensors can be incorporated into garments in many ways, for example, by weaving, or knitting, or braiding into a garment's fabric; or by being sewn or carried on, or mounted in, or attached to the garment; also flexible sensors can be glued, printed, sprayed and so forth onto inner or outer garment surfaces. See, e.g., U.S. Pat. Nos. 6,551,252 and 6,047,203.
- FIG. 6A illustrates shirt-like garment 125 to which sensors 127 and 129 are affixed or attached. This garment can be joined by a zipper, Velcro, or the like along the ventral midline; optionally it can be one piece.
- Size sensor gathers signals responsive to size indicia describing portions of a monitored subject's body, e.g., the torso, the neck, the extremities, or parts thereof. Size sensor signals can be processed to yield information about organ system functioning. In particular, signals from size sensors at one or more levels of the torso, e.g., at an abdominal level and at a rib cage level, can be interpreted using a two-component breathing model in order to determine respiratory rates, respiratory volumes, respiratory events, and the like. See, e.g., U.S. Pat. Nos. 6,551,252; 5,159,935; 4,777,962; and U.S. patent application Ser. No. 10/822,260.
- Preferred size sensors are based on inductive plethysmographic (IP) technologies.
- IP inductive plethysmographic
- the impedance of a conductive element is known to reflect size and shape of the element. Therefore, the impedance of a conductive element configured to lie on a portion of a body part, or to partially or fully encircle a body part, or otherwise arranged on the body of a subject changes as the size of the underlying body part changes due to, e.g., respirations, pulsations, voluntary motions, cardiac activity, and the like. IP technology measures this impedance and consequently reflects such physiological functioning.
- useful size sensors can be based on diverse other technologies known in the art. Active elements of size sensors can be based on thread and fabric technologies.
- the exemplary garment of FIG. 6A includes two size sensors 127 at rib cage and abdominal levels, which return signals that can be processed into respiratory information.
- wearable items can include diverse additional sensors for other physiological and/or non-physiological parameters of a monitored subject.
- accelerometers can sense current activity level and body posture or orientations; thermistors can sense skin or body core temperature; pulse oximeters can sense blood oxygen level.
- electrodes in electrical communication with the subject can sensor such electrical activities as electrocardiogram (“ECG”) signals, electroencephalogram (“EEG”) signals, electro-oculogram (“EOG”) signals, electro-myogram (“EMG”) signals (of the orbital, facial and other muscles), skin conductance or resistance, and the like.
- ECG electrocardiogram
- EEG electroencephalogram
- EEG electro-oculogram
- EMG electro-myogram
- EMG electro-myogram
- FIG. 6A illustrates ECG electrodes 129 in contact with the subject through cutouts in garment 125 .
- ECG electrodes can be mounted on the inner surface of garment 125 to be directly in contact with the subject's skin, thus obviating garment cutouts.
- PDUs portable data units
- PDUs preferably include IP sensor electronics and also electronics for operating other sensors, and for retrieving and digitizing (if necessary) sensor data. See, e.g., U.S. Pat. No. 6,551,252.
- PDUs are also preferably in two-way communication, wired or wireless with physically local or physically remote external server systems so that sensor data can transmitted in real time. Alternatively, sensor data can be stored for later access on, e.g., flash memory, or magnetic media, hard drives, or the like.
- FIG. 6A illustrates PDUs 131 connected by wire to the garment sensors and in wireless contact with external server system 121 .
- Server system 121 can be a PC-type or workstation-type computer both of which are well known in the art.
- User interface devices such a display, mouse, and keyboard 123 , preferably accompany server systems for use by monitoring personnel.
- Sensor signal processing whether in a PDU or in an external systems generally includes filtering, digitization, noise limiting, extraction of relevant signal components, specific processing of respiratory size sensor signals. See, e.g., U.S. Pat. Nos. 6,413,225; 5,159,935; 4,834,766; 4,777,962; and U.S. application Ser. No. 10/822,260.
- Signals from other sensors can also be processed: R-waves can be recognized in ECG signals using known methods; accelerometer signals can be low and high pass filters to extract posture information and activity level information, respectively; and so forth. See, e.g., U.S. application Ser. No. 10/991,877.
- This methods of this invention are performed on software or firmware programmable systems.
- methods are coded in standard computer languages, such as C, C++, or in high level application languages, such as Matlab and associated toolboxes (Math Works, Natick, Mass.). Code is then translated or compiled into executable computer instructions for controlling a microprocessor or similar.
- firmware programming higher level method specifications written in software languages or hardware languages such as VHDL, are generally translated into bit codes by tools supplied by the manufacturer of the hardware part that is being programmed. For example, manufacturer's tools prepare bit-streams for configuring FPGAs.
- the invention also includes software distributions, e.g., on computer-readable media, having encoded the method of this invention for execution on a computer or for programming a firmware device.
- the smoking analysis methods of this invention are implemented as software programs that are preferably executed on server systems that receive data from one or more ambulatory monitoring devices.
- these software programs can be executed on server system 121 with input data received from monitoring garment 125 through PDU 131 .
- FIG. 6B illustrates a flowchart for an exemplary software implementation.
- the first steps searches for puffs in input data 151 received directly or indirectly from an ambulatory monitoring device.
- a tidal volume (Vt) waveform is obtain for this data and searched 153 for breaths with the above-described puff-indicating features. If a breath is found having sufficient puff-like features, it is determined that a puff has been found 155 ; otherwise the program continues searching Vt data. Sufficient features can be found if a breath has a threshold number of features that are optionally weighted by their significance, or if a breath has a number of required features and a threshold number of optional features, or the like.
- puff identification can be suspended during periods of activity, as indicated by input accelerometer data, sufficient to cause puff identification to be unreliable.
- Puffs and their times of occurrence are then summarized 157 by known statistical methods (e.g., totals, means, standard deviations, and the like) to produce characteristics describing a subject's overall smoking behavior.
- the next steps determine its morphology. Accordingly, the identified puff is searched for key morphological features 159 such as type and volume of inhalation, type and volume of exhalation, duration of breath holding, if any, and the volume during breath holding, and the like. Puff morphology is determined from the features found and statistical data is maintained 163 on the types of subject puffs, such as average duration and its standard deviation, percent of breath holding time, relative tidal volume, and the like. Number of puffs of various types, such as the above-described types, can also be maintained. The implementation then resumes receiving input data 151 and searching it 153 for puffs.
- key morphological features 159 such as type and volume of inhalation, type and volume of exhalation, duration of breath holding, if any, and the volume during breath holding, and the like.
- Puff morphology is determined from the features found and statistical data is maintained 163 on the types of subject puffs, such as average duration and its standard deviation, percent of breath holding time, relative tidal volume
- sufficient data is accumulated, it is preferably further processed. At least, it is displayed for analysis. Further, it can be correlated with other physiological monitoring data. Also, with reference to smoking behavior databases, prognostic information can be estimated for the subject. Also, it can be used as biofeedback to aid in smoking cessation or amelioration.
Abstract
Description
- This application claims the benefit of U.S. provisional application No. 60/781,468 filed Mar. 9, 2006, the entire content of which is included herein by reference in its entirety for all purposes.
- The present invention is related to ambulatory physiological monitoring, and in particular to automatic systems and methods that quantify a subject's overall smoking behaviors over time and that quantify characteristics of the subject's method of smoking, e.g., the nature of the subject's puffs.
- Smoking, whether of cigarettes, cigars, pipes, or other smoking materials, is well known as a serious health problem worldwide leading to significant morbidity and mortality primarily from induced lung disease. It is advantageous to provide smokers with facilities and information to aid them to cease smoking, or to limit smoking, or to smoke in less pathogenic ways. It is also advantageous to estimate the likelihood and severity of possible lung disease in dependence on a subject's smoking behavior. It is also advantageous to monitor and to quantify the average smoking behaviors of several subjects and/or of populations of subjects for public health, research, and other purposes.
- Automatic systems and methods to monitor and quantify a subject's smoking behaviors over time and to monitor and quantify the characteristics of the subject's method of smoking are not available in the prior art.
- Objects of the present invention are to provide systems and computer-implemented methods that provide smokers with such information.
- This invention includes the use of an ambulatory cardio-respiratory monitoring system to provide data that can be processed and interpreted to monitor and quantify specific characteristics of a subject's cigarette and other types of smoking. This monitoring will enable a greater understanding of the interaction between smoker and cigarette, or other smoking material. It will also aid individual smokers to cease, limit, or improve their smoking behaviors.
- The invention provides methods to analyze ambulatory and/or clinical and/or laboratory monitoring data to characterize a subject's overall smoking behavior and details of the subject's smoking behavior, i.e., characteristics of the subject's individual puffs and overall puffing pattern, and how these behaviors very with different smoking materials. Overall smoking is determined in dependence on the number of puffs and on the times of their occurrence as revealed by the monitoring data. The invention identifies specific characteristics that indicate a breath is a puff, and further identifies important morphological characteristics of individual puffs. In preferred embodiments, computer-implemented methods examine tidal volume (Vt) data for puff-indicating characteristics to identify puffs. Further, it is preferred that these computer-implemented methods also examine Vt data of each puff to identify important morphological characteristics. Puff occurrence data and puff morphology data are retained and statistically summarized in order to provide characterization of all aspects of a subject's smoking behavior, i.e., a subject's overall smoking behavior and details of how the subject puffs
- Single puffs can also be monitored and quantified by determining puff inspiratory and puff expiratory volume, flow, and timing. Additionally, effects of smoking on heart rate, heart rate variability, and activity can be correlated if cardiac data is also available. Further, smoking patterns and smoker interaction with their smoking implement can provide diagnostic information related to smoking addiction and prognostic information related to likelihood of development of smoking related diseases.
- Additionally, complete ambulatory and/or clinical and/or laboratory monitoring data, including cardiac, respiratory, and activity data enables detailed correlation of the activities/actions of smoker related to the inspiration, holding, and expiration of smoke and of the effect of smoking on subsequent respiratory pattern, blood oxygen saturation, heart-rate and heart rate variability, pre- and post-smoking physical activity level, and the like. Continuous monitoring during a day and night permits correlation of variations in smoking habits with respiratory pattern and subsequent sleep latency, sleep time and sleep quality.
- Other aspects of the invention include monitoring the ways in which smokers smoke cigarettes of different types, such a filtered, non-filtered, menthol, low-tar, etc, and with cigars, pipes and other smoking implements. Other aspects of the invention include use of monitoring data as bio-feedback information for smokers wishing to modify their smoking behaviors in order to wean themselves from the smoking related nicotine addiction. Other aspects of the invention include the use of smoking behavior data to estimate the likelihood and severity of smoking associated diseases with more accuracy than estimates based on “packs per day” smoked. Other aspects of the invention include collecting smoking behavior data from various subject populations and storing this data in databases for various public health, research, and other purposes.
- A preferred ambulatory monitoring system is capable of monitoring tidal volume, the relative contributions of rib cage and abdominal expansion to tidal volume, heart rate, ECG, motion, blood oxygen saturation, posture, and activity. Such systems are available from VivoMetrics, Inc., Ventura, Calif.
- The present invention may be understood more fully by reference to the following detailed description of the preferred embodiment of the present invention, illustrative examples of specific embodiments of the invention and the appended figures in which:
-
FIG. 1 illustrates a 5 minute and 45 second smoking record; -
FIG. 2 illustrates morphology of a first puff; -
FIG. 3 illustrates morphology of a second puff; -
FIG. 4 illustrates morphology of a third puff; -
FIG. 5 illustrates morphology of a fourth puff; and -
FIGS. 6A-B illustrates a preferred ambulatory monitoring system and exemplary embodiments of the methods of this invention. - Preferred embodiments of the invention are now described. These embodiments do not limit the scope of the invention, since these embodiments are illustrations of several preferred aspects of the invention. Any equivalent embodiments are intended to be within the scope of this invention. Indeed, various modifications of the invention in addition to those shown and described herein, such as alternate useful combinations of the elements described, will become apparent to those skilled in the art from the subsequent description. Such modifications and combinations are also intended to fall within the scope of the appended claims. In the following (and in the application as a whole), headings and legends are used for clarity and convenience only.
- This invention is useful for subjects that are monitored while ambulatory or that are monitored while in the clinic. This invention is further useful for laboratory monitoring and studies. Although, this invention may be described as “ambulatory”, or as “clinical”, or as laboratory” in this application, use of these words individually in not intended to limit the applicability of this invention.
- The act of smoking results in characteristic patterns of cardio-respiratory, ambulatory monitoring data. The present invention provides systems and computer-implemented methods to recognize and to quantify these characteristic patterns. These methods are now described with reference to
FIG. 1-4 , which illustrate exemplary smoking patterns. Preferred ambulatory monitoring devices and data analysis systems are described subsequently. - Methods of this invention can be broadly divided, first, into those that recognize puffs in cardio-respiratory data and then quantify a subject's overall smoking behavior over time (smoking behavior methods) in dependence on recognized puffs. A second group of methods are those that examine each puff in detail in order to quantify and classify the subject's manner of smoking (manner of smoking methods or puff morphology methods).
- Turning first to smoking behavior methods,
FIG. 1 illustrates cardio-respiratory monitoring data from a subject during a 5 min. 45 sec period of smoking. The Vt trace is the subject's tidal volume; the RC and AB traces are expansions and contractions of the subject's rib cage and abdomen, respectively; the spikes on the trace labeled Br/M mark the beginning of each breath and the height of a spike indicates the volume of the associated breath; the height of spikes in the trace labeled Ve/Vol trace indicate the expiratory volume of the associated breath; the ECG trace is the concurrent electrocardiogram; the HR trace is the heart rate; and the ACC trace is accelerometer data reflecting subject activity. During this period, the subject puffed 14 times as indicated by the highlighted bands. These puffs have distinguishing characteristics, and the computer-implemented methods of the invention recognize occurrences of puffs by examining the record for these distinguishing characteristics. -
Puffs 11 illustrate the waveform characteristics and features signaling a puff. First, puffs typically have durations approximately 2.5 to 3.0 times longer than the durations of adjacent breaths, and amplitudes approximately 2 times greater than the amplitudes of adjacent breaths. - Second, puffs have a characteristic shape, again illustrated by
puffs 11. A puff is a single breath with a single inspiratory phase and a single expiratory phase. In most cases, the slope of the expiratory phase is substantially constant or slowly varying (the relative change in slope being less than approximately 50%). However, the inspiratory phase often includes two segments of similar slope separated by an intervening period of low to zero but never negative. That is, exhalation does not occur in the intervening period. However, the slope of the inspiratory phase is also often substantially constant or slowly varying. The inspiratory and expiratory phases can be separated by breath-holding periods at substantially constant but elevated lung volume. - Accordingly, one primary feature signaling a puff is a breath with a duration and amplitude both of which approximately 1.5 to 2.0 times longer or greater, respectively, than adjacent breaths. The greater these deviations, the greater is the confidence that the particular breath is a puff. A further primary signaling feature a substantially single inspiratory phase, which may be interrupted by a period at a substantially constant lung volume, and a substantially single expiratory phase. A breath holding period at a substantially constant, elevated lung volume may separate inhalation and exhalation. A puff characteristically has no further structure. In fact, further structure indicates the breath is not likely to be a puff, being instead, perhaps, a cough, or a sigh, or a period of speech, or the like. A secondary feature is heart rate which is usually decreasing over most of the puffs duration.
- Thus, a puff is preferably identified as a breath having a pre-determined combination of these primary and secondary features, presence of absence of features being determined by computer-implemented examination of monitoring data. Puffs are most reliably recognized during periods of limited subject activity, which can be indicated by a motion sensor, e.g., an accelerometer, that is part of the ambulatory monitoring apparatus. In
FIG. 1 , the ACC trace is an accelerometer trace indicating limited subject activity. During more intense activity, normally increased minute ventilation and motion artifacts can mimic some of all of the features of puffs. Optionally, puff identification can be suspended during such activity and the period of suspension noted in the data set. - Overall smoking behaviors can be abstracted from identified puff occurrences and the times of puff occurrence. For example, the total puffs during a day can be counted. This measure is expected to be a more reliable indicator of pulmonary exposure to tobacco smoke than is the number of cigarettes (or packs) smoked per day. Further, the number smoking periods during a day as well as their length and time of occurrence can be summarized. Further, these quantitative measures of smoking can be correlated with patterns in other cardio-respiratory parameters, such as heart rate and its variability and breath rate, tidal volume, and the like and their variability. Further, for monitoring that extends over all or part of a day and the following night, quantitative measures of smoking can be correlated with objective measures of sleep time and quality in order to ascertain effects of smoking on sleep. Sleep can be assessed by time spent in various sleep stages, the number of nocturnal arousals, and the like. In preferred embodiments, sleep parameters and determined from cardio-respiratory and motion monitoring data. See <<<non-eeg sleep>>> application included in its entirety herein by reference for all purposes.
- Turning next to the manner of smoking methods, puff morphology is important in improving estimates of pulmonary exposure to tobacco smoke, which are initially provided by the smoking behavior methods. Different puff morphologies are known to result in lesser or greater smoke exposure. Shorter puffs, and puffs consisting of a single inspiration followed closely by a single expiration without noticeable breath holding, limit both smoke exposure time and location of smoke exposure in the pulmonary tree. In particular, such puffs result in reduced smoke and particulate exposure of the smaller bronchioles and alveoli. These pulmonary components are more sensitive to smoke-induced injury causing ultimately to emphysema and/or COPD. On the other hand, longer puffs and puffs with breath holding provide more time for distribution and diffusion of smoke and particulates in the respiratory tree, leading to increased smoke and particulate exposure of the smaller bronchioles and alveoli receive and to increased likelihood of their injury. Further, a puff primarily due to rib cage expansion tends to lead to only limited smoke exposure in the peripheral airways. Conversely, a puff with relatively equal expansion of the rib cage and the abdomen tends to cause increase smoke exposure in the peripheral airways. Since puff morphology affects airway smoke exposure, this morphology can provide prognostic information concerning the occurrence and severity of smoking related lung diseases.
- Accordingly, methods of the second class preferably recognize additional features in the tidal volume trace including, for one or more previously identified puffs: duration in seconds; presence or absence of a reduced-amplitude puff prior to the primary inhalation; relative importance of rib cage and abdominal motions in the puff; relative duration of inhalation and of exhalation; whether inhalation and exhalation are smooth or any interrupted with multiple phases; duration of breath holding if any; lung volume during breath holding; and the like. Total duration of a true puff is approximately the duration of any reduced prior puff, plus the duration of inhalation, plus the duration of any breath holding, and plus the duration of exhalation.
FIGS. 2-4 illustrate puffs of various types which illustrate these waveform features. -
FIG. 2 illustrates a mono-phasic-type puff which is simply an inhalation followed by an exhalation without significant breath holding. This type of puff includes the following features: reducedinitial puff 21, followed byprimary inhalation 23 andprimary exhalation 25. Both the inhalation and exhalation have slopes that are smoothly varying without evident phases or interruptions. This puff has no breath holding between inhalation and exhalation, andrib cage expansion 27 makes a significantly greater contribution to this puff than doesabdominal expansion 29. -
FIG. 3 illustrates a puff with a single breath holding phase but it otherwise generally similar to the puff ofFIG. 2 . This puff includes the following features: reducedinitial puff 41;inhalation 43 with smoothly varying slope; breath holding 45 after partial expiration; andexhalation 49. Again, the inhalation and exhalation have smoothly varying slopes with the lung volume at the end of exhalation lower than the lung volume at start of inhalation. Breath-holding-period duration is less than 50% of puff duration and includes a slow exhalation; it is therefore a less prominent breath holding. The height ofindicator 49 is proportional to expiratory volume and time of expiration. Here, the contribution ofrib cage expansion 42 andabdominal expansion 44 are more comparable although rib cage expansion still dominates. -
FIG. 4 illustrates a puff with more prominent breath holding. Here, breath holding 55 is more prominent: it extends for more than half the pulse duration; lung volume during breath holding is approximately at an end-inspiratory volume comparable to adjacent breaths; and the lung volume is substantially constant during breath holding. Also, the contribution ofrib cage expansion 52 is here only marginally greater than the contribution ofabdominal expansion 54. The height ofindicator 59 represents a large expiration prior to inhalation.Inhalation 53 andexhalation 57 again have smoothly varying slopes with phases or interruptions. -
FIG. 5 illustrates very prominent breath holding at high lung volumes along with a biphasic inhalation. The inhalation displays aninitial phase 71 followed by abreath holding interruption 73 at an approximately constant lung volume that is considerably higher than the end-inspiratory volume of adjacent breaths. Inhalation resumes 75 drawing more smoke into the lungs and distributing the already-present smoke further into the lung periphery. Following this inhalation phase is a further period of breath holding 77 at an even higher lung volume. These breath holding periods inhale a volume of smoke that is 2 to 3 times the tidal volume of adjacent normal breaths. This puff ends withsmooth expiration 79 back to the lung volume and the beginning of inhalation. Here, approximatelyequal rib cage 72 and abdominal 74 expansions are needed to inhale and hold this significant volume of smoke. - Accordingly, a basic morphological classification of puffs preferably includes at least the duration and volume of the puff in comparison to adjacent normal breaths, and the relative duration of breath holding and the lung volume during breath holding, again in comparison to adjacent normal breaths.
- Preferred ambulatory monitoring and data analysis systems are now described which gather the data analyzed by the described smoking behavior and puff morphology methods. Physiological data can be gathered by a wide variety of monitoring systems designed for, e.g., in-hospital use, or in-clinic use, or ambulatory use, or other uses. Without limitation or prejudice, however, the following description is largely in terms of preferred monitoring systems for ambulatory use.
- In order to perform normal daily waking and sleeping activities, a monitored subject should be only minimally, if at all, constrained by a monitoring device. In preferred embodiments, therefore, physiological sensors are attached to, or affixed to, or carried by, or incorporated in or as part of ordinary wearable items that are unobtrusive, comfortable, and useable without assistance. Suitable wearable items include garments, jackets, bands, patches, and the like, made from a variety of materials, particularly elastic materials to insure a snug fit; they can be donned in one piece or include zippers, Velcro, snaps, and the like, that are joined after donning. Sensors can be incorporated into garments in many ways, for example, by weaving, or knitting, or braiding into a garment's fabric; or by being sewn or carried on, or mounted in, or attached to the garment; also flexible sensors can be glued, printed, sprayed and so forth onto inner or outer garment surfaces. See, e.g., U.S. Pat. Nos. 6,551,252 and 6,047,203. For example,
FIG. 6A illustrates shirt-like garment 125 to whichsensors - Many types of sensors can be incorporated in wearable, monitoring items. One useful physiological sensor, referred to herein generically as a “size sensor”, gathers signals responsive to size indicia describing portions of a monitored subject's body, e.g., the torso, the neck, the extremities, or parts thereof. Size sensor signals can be processed to yield information about organ system functioning. In particular, signals from size sensors at one or more levels of the torso, e.g., at an abdominal level and at a rib cage level, can be interpreted using a two-component breathing model in order to determine respiratory rates, respiratory volumes, respiratory events, and the like. See, e.g., U.S. Pat. Nos. 6,551,252; 5,159,935; 4,777,962; and U.S. patent application Ser. No. 10/822,260.
- Preferred size sensors are based on inductive plethysmographic (IP) technologies. Briefly, the impedance of a conductive element is known to reflect size and shape of the element. Therefore, the impedance of a conductive element configured to lie on a portion of a body part, or to partially or fully encircle a body part, or otherwise arranged on the body of a subject changes as the size of the underlying body part changes due to, e.g., respirations, pulsations, voluntary motions, cardiac activity, and the like. IP technology measures this impedance and consequently reflects such physiological functioning. However, useful size sensors can be based on diverse other technologies known in the art. Active elements of size sensors can be based on thread and fabric technologies. The exemplary garment of
FIG. 6A includes twosize sensors 127 at rib cage and abdominal levels, which return signals that can be processed into respiratory information. - In addition to size sensors providing respiratory and/or cardiac information, wearable items can include diverse additional sensors for other physiological and/or non-physiological parameters of a monitored subject. For example, accelerometers can sense current activity level and body posture or orientations; thermistors can sense skin or body core temperature; pulse oximeters can sense blood oxygen level. Further, electrodes in electrical communication with the subject can sensor such electrical activities as electrocardiogram (“ECG”) signals, electroencephalogram (“EEG”) signals, electro-oculogram (“EOG”) signals, electro-myogram (“EMG”) signals (of the orbital, facial and other muscles), skin conductance or resistance, and the like. These electrodes can be as known in the art of can be fabric based, or are otherwise flexible. Additional sensor can be mounted or incorporated in various manners.
FIG. 6A illustratesECG electrodes 129 in contact with the subject through cutouts ingarment 125. Alternatively ECG electrodes can be mounted on the inner surface ofgarment 125 to be directly in contact with the subject's skin, thus obviating garment cutouts. - Wearable items are usually accompanied by local electronic units, referred to herein as portable data units (“PDUs”) that are sufficiently compact and lightweight to be carried on or by the monitored subject. PDUs preferably include IP sensor electronics and also electronics for operating other sensors, and for retrieving and digitizing (if necessary) sensor data. See, e.g., U.S. Pat. No. 6,551,252. PDUs are also preferably in two-way communication, wired or wireless with physically local or physically remote external server systems so that sensor data can transmitted in real time. Alternatively, sensor data can be stored for later access on, e.g., flash memory, or magnetic media, hard drives, or the like.
- External server systems typically receive and store data from one or more PDUs, perform additional processing of received data to determine further physiological information, and format and display received for monitoring personnel. In preferred embodiments, the methods of this invention are implemented on such external systems.
FIG. 6A illustratesPDUs 131 connected by wire to the garment sensors and in wireless contact withexternal server system 121.Server system 121 can be a PC-type or workstation-type computer both of which are well known in the art. User interface devices, such a display, mouse, andkeyboard 123, preferably accompany server systems for use by monitoring personnel. - Sensor signal processing whether in a PDU or in an external systems generally includes filtering, digitization, noise limiting, extraction of relevant signal components, specific processing of respiratory size sensor signals. See, e.g., U.S. Pat. Nos. 6,413,225; 5,159,935; 4,834,766; 4,777,962; and U.S. application Ser. No. 10/822,260. Signals from other sensors can also be processed: R-waves can be recognized in ECG signals using known methods; accelerometer signals can be low and high pass filters to extract posture information and activity level information, respectively; and so forth. See, e.g., U.S. application Ser. No. 10/991,877.
- This methods of this invention are performed on software or firmware programmable systems. In the case of software programming, methods are coded in standard computer languages, such as C, C++, or in high level application languages, such as Matlab and associated toolboxes (Math Works, Natick, Mass.). Code is then translated or compiled into executable computer instructions for controlling a microprocessor or similar. In the case of firmware programming, higher level method specifications written in software languages or hardware languages such as VHDL, are generally translated into bit codes by tools supplied by the manufacturer of the hardware part that is being programmed. For example, manufacturer's tools prepare bit-streams for configuring FPGAs. The invention also includes software distributions, e.g., on computer-readable media, having encoded the method of this invention for execution on a computer or for programming a firmware device.
- The smoking analysis methods of this invention are implemented as software programs that are preferably executed on server systems that receive data from one or more ambulatory monitoring devices. For example with reference to
FIG. 6A , these software programs can be executed onserver system 121 with input data received from monitoringgarment 125 throughPDU 131. -
FIG. 6B illustrates a flowchart for an exemplary software implementation. The first steps searches for puffs ininput data 151 received directly or indirectly from an ambulatory monitoring device. A tidal volume (Vt) waveform is obtain for this data and searched 153 for breaths with the above-described puff-indicating features. If a breath is found having sufficient puff-like features, it is determined that a puff has been found 155; otherwise the program continues searching Vt data. Sufficient features can be found if a breath has a threshold number of features that are optionally weighted by their significance, or if a breath has a number of required features and a threshold number of optional features, or the like. Optionally, puff identification can be suspended during periods of activity, as indicated by input accelerometer data, sufficient to cause puff identification to be unreliable. Puffs and their times of occurrence are then summarized 157 by known statistical methods (e.g., totals, means, standard deviations, and the like) to produce characteristics describing a subject's overall smoking behavior. - Having identified a puff, the next steps determine its morphology. Accordingly, the identified puff is searched for key
morphological features 159 such as type and volume of inhalation, type and volume of exhalation, duration of breath holding, if any, and the volume during breath holding, and the like. Puff morphology is determined from the features found and statistical data is maintained 163 on the types of subject puffs, such as average duration and its standard deviation, percent of breath holding time, relative tidal volume, and the like. Number of puffs of various types, such as the above-described types, can also be maintained. The implementation then resumes receivinginput data 151 and searching it 153 for puffs. - Once sufficient data is accumulated, it is preferably further processed. At least, it is displayed for analysis. Further, it can be correlated with other physiological monitoring data. Also, with reference to smoking behavior databases, prognostic information can be estimated for the subject. Also, it can be used as biofeedback to aid in smoking cessation or amelioration.
- A number of references are cited herein, including patents and patent applications, the entire disclosures of which are incorporated herein, in their entirety, by reference for all purposes. Further, none of these references, regardless of how characterized above, is admitted as prior to the invention of the subject matter claimed herein.
- Although specific features of the invention are shown in some drawings and not in others, this is for convenience only as each feature may be combined with any or all of the other features in accordance with the invention. The words “including”, “comprising”, “having”, and “with” as used herein are to be interpreted broadly and comprehensively and are not limited to any physical interconnection. Moreover, any embodiments disclosed in the subject application are not to be taken as the only possible embodiments. Other embodiments will occur to those skilled in the art and are within the following claims.
- In addition, any amendment presented during the prosecution of the patent application for this patent is not a disclaimer of any claim element presented in the application as filed: those skilled in the art cannot reasonably be expected to draft a claim that would literally encompass all possible equivalents, many equivalents will be unforeseeable at the time of the amendment and are beyond a fair interpretation of what is to be surrendered (if anything), the rationale underlying the amendment may bear no more than a tangential relation to many equivalents, and/or there are many other reasons the applicant can not be expected to describe certain insubstantial substitutes for any claim element amended.
Claims (13)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/682,601 US20070209669A1 (en) | 2006-03-09 | 2007-03-06 | Monitoring and quantification of smoking behaviors |
PCT/US2007/005707 WO2007103380A2 (en) | 2006-03-09 | 2007-03-07 | Monitoring and quantification of smoking behaviors |
JP2008558358A JP5128505B2 (en) | 2006-03-09 | 2007-03-07 | Monitoring and quantification of smoking behavior |
CA002645027A CA2645027A1 (en) | 2006-03-09 | 2007-03-07 | Monitoring and quantification of smoking behaviors |
AU2007223995A AU2007223995A1 (en) | 2006-03-09 | 2007-03-07 | Monitoring and quantification of smoking behaviors |
EP07752409.8A EP1991122B1 (en) | 2006-03-09 | 2007-03-07 | Monitoring and quantification of smoking behaviors |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78146806P | 2006-03-09 | 2006-03-09 | |
US11/682,601 US20070209669A1 (en) | 2006-03-09 | 2007-03-06 | Monitoring and quantification of smoking behaviors |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070209669A1 true US20070209669A1 (en) | 2007-09-13 |
Family
ID=38475508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/682,601 Abandoned US20070209669A1 (en) | 2006-03-09 | 2007-03-06 | Monitoring and quantification of smoking behaviors |
Country Status (6)
Country | Link |
---|---|
US (1) | US20070209669A1 (en) |
EP (1) | EP1991122B1 (en) |
JP (1) | JP5128505B2 (en) |
AU (1) | AU2007223995A1 (en) |
CA (1) | CA2645027A1 (en) |
WO (1) | WO2007103380A2 (en) |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080164999A1 (en) * | 2007-01-10 | 2008-07-10 | Halo Monitoring, Inc. | Wireless Sensor Network Context Data Delivery System and Method |
US20090048540A1 (en) * | 2007-08-15 | 2009-02-19 | Otto Chris A | Wearable Health Monitoring Device and Methods for Fall Detection |
US20100305958A1 (en) * | 2007-11-30 | 2010-12-02 | Japan Tobacco, Inc. | Data processing system, computer program used therefor, and data processing method |
US20100312570A1 (en) * | 2007-11-30 | 2010-12-09 | Hisaaki Shimo | Data processing system |
US8033996B2 (en) | 2005-07-26 | 2011-10-11 | Adidas Ag | Computer interfaces including physiologically guided avatars |
WO2011131235A1 (en) * | 2010-04-20 | 2011-10-27 | Wearable Information Technologies, S.L. (Weartech) | Monitoring system |
US8475387B2 (en) | 2006-06-20 | 2013-07-02 | Adidas Ag | Automatic and ambulatory monitoring of congestive heart failure patients |
US8628480B2 (en) | 2005-05-20 | 2014-01-14 | Adidas Ag | Methods and systems for monitoring respiratory data |
US8762733B2 (en) | 2006-01-30 | 2014-06-24 | Adidas Ag | System and method for identity confirmation using physiologic biometrics to determine a physiologic fingerprint |
US8868616B1 (en) | 2011-07-07 | 2014-10-21 | Integrity Tracking, Llc | Event data monitoring systems and methods |
WO2015026000A1 (en) * | 2013-08-23 | 2015-02-26 | 케이티메드 주식회사 | Health education apparatus |
US20150065825A1 (en) * | 2009-10-24 | 2015-03-05 | David Scott Utley | Extracorporeal Devices and Methods for Facilitating Cessation of Undesired Behaviors |
US20150119675A1 (en) * | 2013-10-25 | 2015-04-30 | Seiko Instruments Inc. | Garment |
CN104970442A (en) * | 2014-04-03 | 2015-10-14 | 惠州市吉瑞科技有限公司 | Information interaction method and system |
US9462975B2 (en) | 1997-03-17 | 2016-10-11 | Adidas Ag | Systems and methods for ambulatory monitoring of physiological signs |
US9492084B2 (en) | 2004-06-18 | 2016-11-15 | Adidas Ag | Systems and methods for monitoring subjects in potential physiological distress |
US9504410B2 (en) | 2005-09-21 | 2016-11-29 | Adidas Ag | Band-like garment for physiological monitoring |
US9675275B2 (en) | 2009-10-24 | 2017-06-13 | Carrot Sense, Inc. | Extracorporeal devices and methods for facilitating cessation of undesired behaviors |
US9833184B2 (en) | 2006-10-27 | 2017-12-05 | Adidas Ag | Identification of emotional states using physiological responses |
US9861126B2 (en) | 2015-04-07 | 2018-01-09 | Carrot, Inc. | Systems and methods for quantification of, and prediction of smoking behavior |
US10206572B1 (en) | 2017-10-10 | 2019-02-19 | Carrot, Inc. | Systems and methods for quantification of, and prediction of smoking behavior |
CN111134365A (en) * | 2018-11-02 | 2020-05-12 | 日本烟草产业株式会社 | Smoke supply device and personal health state evaluation system |
US20200303058A1 (en) * | 2017-12-18 | 2020-09-24 | Omron Corporation | Lifestyle habit management device, method, and non-transitory recording medium in which program is stored |
US11257583B2 (en) | 2019-12-30 | 2022-02-22 | Carrot, Inc. | Systems and methods for assisting individuals in a behavioral-change program |
US11273283B2 (en) | 2017-12-31 | 2022-03-15 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
US11452839B2 (en) | 2018-09-14 | 2022-09-27 | Neuroenhancement Lab, LLC | System and method of improving sleep |
US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
US11723579B2 (en) | 2017-09-19 | 2023-08-15 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement |
US11786694B2 (en) | 2019-05-24 | 2023-10-17 | NeuroLight, Inc. | Device, method, and app for facilitating sleep |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2507104A (en) * | 2012-10-19 | 2014-04-23 | Nicoventures Holdings Ltd | Electronic inhalation device |
GB201517089D0 (en) | 2015-09-28 | 2015-11-11 | Nicoventures Holdings Ltd | Vaping heat map system and method for electronic vapour provision systems |
CN112859652B (en) * | 2021-01-20 | 2022-03-29 | 青岛海尔空调器有限总公司 | Indoor smoking monitoring method and monitoring device |
Citations (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4016868A (en) * | 1975-11-25 | 1977-04-12 | Allison Robert D | Garment for impedance plethysmograph use |
US4273534A (en) * | 1979-08-27 | 1981-06-16 | Sultan Dental Products, Inc. | Amalgam carrier and dispenser |
US4306567A (en) * | 1977-12-22 | 1981-12-22 | Krasner Jerome L | Detection and monitoring device |
US4308872A (en) * | 1977-04-07 | 1982-01-05 | Respitrace Corporation | Method and apparatus for monitoring respiration |
US4433693A (en) * | 1979-09-27 | 1984-02-28 | Hochstein Peter A | Method and assembly for monitoring respiration and detecting apnea |
US4452252A (en) * | 1981-05-26 | 1984-06-05 | Respitrace Corporation | Non-invasive method for monitoring cardiopulmonary parameters |
US4456015A (en) * | 1981-05-26 | 1984-06-26 | Respitrace Corporation | Non-invasive method for semiquantitative measurement of neck volume changes |
US4463764A (en) * | 1981-09-29 | 1984-08-07 | Medical Graphics Corporation | Cardiopulmonary exercise system |
US4597394A (en) * | 1981-05-26 | 1986-07-01 | Respitrace Corporation | Method for noninvasively monitoring mouth volume |
US4648407A (en) * | 1985-07-08 | 1987-03-10 | Respitrace Corporation | Method for detecting and differentiating central and obstructive apneas in newborns |
US4753988A (en) * | 1987-02-18 | 1988-06-28 | The Dow Chemical Company | High gloss acrylate rubber-modified weatherable resins |
US4777962A (en) * | 1986-05-09 | 1988-10-18 | Respitrace Corporation | Method and apparatus for distinguishing central obstructive and mixed apneas by external monitoring devices which measure rib cage and abdominal compartmental excursions during respiration |
US4796639A (en) * | 1987-11-05 | 1989-01-10 | Medical Graphics Corporation | Pulmonary diagnostic system |
US4800495A (en) * | 1986-08-18 | 1989-01-24 | Physio-Control Corporation | Method and apparatus for processing signals used in oximetry |
US4807640A (en) * | 1986-11-19 | 1989-02-28 | Respitrace Corporation | Stretchable band-type transducer particularly suited for respiration monitoring apparatus |
US4817625A (en) * | 1987-04-24 | 1989-04-04 | Laughton Miles | Self-inductance sensor |
US4834766A (en) * | 1987-11-24 | 1989-05-30 | Sando Iron Works Co., Ltd. | Method for preventing scale adhesion |
US4834109A (en) * | 1986-01-21 | 1989-05-30 | Respitrace Corporation | Single position non-invasive calibration technique |
US4860766A (en) * | 1983-11-18 | 1989-08-29 | Respitrace Corp. | Noninvasive method for measuring and monitoring intrapleural pressure in newborns |
US4960118A (en) * | 1989-05-01 | 1990-10-02 | Pennock Bernard E | Method and apparatus for measuring respiratory flow |
US4966155A (en) * | 1985-01-31 | 1990-10-30 | The University Of Strathclyde | Apparatus for monitoring physiological parameters |
US4972842A (en) * | 1988-06-09 | 1990-11-27 | Vital Signals, Inc. | Method and apparatus for precision monitoring of infants on assisted ventilation |
US4986277A (en) * | 1988-08-24 | 1991-01-22 | Sackner Marvin A | Method and apparatus for non-invasive monitoring of central venous pressure |
US5007427A (en) * | 1987-05-07 | 1991-04-16 | Capintec, Inc. | Ambulatory physiological evaluation system including cardiac monitoring |
US5040540A (en) * | 1988-08-24 | 1991-08-20 | Nims, Inc. | Method and apparatus for non-invasive monitoring of central venous pressure, and improved transducer therefor |
US5074129A (en) * | 1989-12-26 | 1991-12-24 | Novtex | Formable fabric |
US5131399A (en) * | 1990-08-06 | 1992-07-21 | Sciarra Michael J | Patient monitoring apparatus and method |
US5159935A (en) * | 1990-03-08 | 1992-11-03 | Nims, Inc. | Non-invasive estimation of individual lung function |
US5178151A (en) * | 1988-04-20 | 1993-01-12 | Sackner Marvin A | System for non-invasive detection of changes of cardiac volumes and aortic pulses |
US5301678A (en) * | 1986-11-19 | 1994-04-12 | Non-Invasive Monitoring System, Inc. | Stretchable band - type transducer particularly suited for use with respiration monitoring apparatus |
US5331968A (en) * | 1990-10-19 | 1994-07-26 | Gerald Williams | Inductive plethysmographic transducers and electronic circuitry therefor |
US5348008A (en) * | 1991-11-25 | 1994-09-20 | Somnus Corporation | Cardiorespiratory alert system |
US5416961A (en) * | 1994-01-26 | 1995-05-23 | Schlegel Corporation | Knitted wire carrier having bonded warp threads and method for forming same |
US5447164A (en) * | 1993-11-08 | 1995-09-05 | Hewlett-Packard Company | Interactive medical information display system and method for displaying user-definable patient events |
USRE35122E (en) * | 1985-04-01 | 1995-12-19 | Nellcor Incorporated | Method and apparatus for detecting optical pulses |
US5533511A (en) * | 1994-01-05 | 1996-07-09 | Vital Insite, Incorporated | Apparatus and method for noninvasive blood pressure measurement |
US5544661A (en) * | 1994-01-13 | 1996-08-13 | Charles L. Davis | Real time ambulatory patient monitor |
US5577510A (en) * | 1995-08-18 | 1996-11-26 | Chittum; William R. | Portable and programmable biofeedback system with switching circuit for voice-message recording and playback |
US5588425A (en) * | 1993-05-21 | 1996-12-31 | Nims, Incorporated | Method and apparatus for discriminating between valid and artifactual pulse waveforms in pulse oximetry |
US5601088A (en) * | 1995-02-17 | 1997-02-11 | Ep Technologies, Inc. | Systems and methods for filtering artifacts from composite signals |
US5694939A (en) * | 1995-10-03 | 1997-12-09 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Autogenic-feedback training exercise (AFTE) method and system |
US5749365A (en) * | 1991-11-07 | 1998-05-12 | Magill; Alan | Health monitoring |
US5820567A (en) * | 1995-11-02 | 1998-10-13 | Healthcare Technology Limited | Heart rate sensing apparatus adapted for chest or earlobe mounted sensor |
US5899855A (en) * | 1992-11-17 | 1999-05-04 | Health Hero Network, Inc. | Modular microprocessor-based health monitoring system |
US5913830A (en) * | 1997-08-20 | 1999-06-22 | Respironics, Inc. | Respiratory inductive plethysmography sensor |
US5991922A (en) * | 1996-12-26 | 1999-11-30 | Banks; David L. | Monitored static electricity dissipation garment |
US6015388A (en) * | 1997-03-17 | 2000-01-18 | Nims, Inc. | Method for analyzing breath waveforms as to their neuromuscular respiratory implications |
US6047203A (en) * | 1997-03-17 | 2000-04-04 | Nims, Inc. | Physiologic signs feedback system |
US6066093A (en) * | 1995-07-28 | 2000-05-23 | Unilead International Inc. | Disposable electrodeless electro-dermal devices |
US6067462A (en) * | 1997-04-14 | 2000-05-23 | Masimo Corporation | Signal processing apparatus and method |
US6070098A (en) * | 1997-01-11 | 2000-05-30 | Circadian Technologies, Inc. | Method of and apparatus for evaluation and mitigation of microsleep events |
US6068568A (en) * | 1996-12-12 | 2000-05-30 | Tsubakimoto Chain Co. | Silent chain |
US6142953A (en) * | 1999-07-08 | 2000-11-07 | Compumedics Sleep Pty Ltd | Respiratory inductive plethysmography band transducer |
US6223072B1 (en) * | 1999-06-08 | 2001-04-24 | Impulse Dynamics N.V. | Apparatus and method for collecting data useful for determining the parameters of an alert window for timing delivery of ETC signals to a heart under varying cardiac conditions |
US6254552B1 (en) * | 1997-10-03 | 2001-07-03 | E.I. Du Pont De Nemours And Company | Intra-coronary radiation devices containing Ce-144 or Ru-106 |
US6261238B1 (en) * | 1996-10-04 | 2001-07-17 | Karmel Medical Acoustic Technologies, Ltd. | Phonopneumograph system |
US6302844B1 (en) * | 1999-03-31 | 2001-10-16 | Walker Digital, Llc | Patient care delivery system |
US6341504B1 (en) * | 2001-01-31 | 2002-01-29 | Vivometrics, Inc. | Composite elastic and wire fabric for physiological monitoring apparel |
US6413225B1 (en) * | 1999-06-18 | 2002-07-02 | Vivometrics, Inc. | Quantitative calibration of breathing monitors with transducers placed on both rib cage and abdomen |
US6436057B1 (en) * | 1999-04-22 | 2002-08-20 | The United States Of America As Represented By The Department Of Health And Human Services, Centers For Disease Control And Prevention | Method and apparatus for cough sound analysis |
US6449504B1 (en) * | 1999-08-20 | 2002-09-10 | Cardiac Pacemakers, Inc. | Arrhythmia display |
US6551252B2 (en) * | 2000-04-17 | 2003-04-22 | Vivometrics, Inc. | Systems and methods for ambulatory monitoring of physiological signs |
US6579231B1 (en) * | 1998-03-27 | 2003-06-17 | Mci Communications Corporation | Personal medical monitoring unit and system |
US6604115B1 (en) * | 1999-11-05 | 2003-08-05 | Ge Marquette Medical Systems, Inc. | Method and apparatus for storing data |
US6633772B2 (en) * | 2000-08-18 | 2003-10-14 | Cygnus, Inc. | Formulation and manipulation of databases of analyte and associated values |
US6656127B1 (en) * | 1999-06-08 | 2003-12-02 | Oridion Breathid Ltd. | Breath test apparatus and methods |
US20040030508A1 (en) * | 2002-08-08 | 2004-02-12 | Likness Mark A. | Method for measuring smoking topography |
US6721594B2 (en) * | 1999-08-24 | 2004-04-13 | Cardiac Pacemakers, Inc. | Arrythmia display |
US6723055B2 (en) * | 1999-04-23 | 2004-04-20 | Trustees Of Tufts College | System for measuring respiratory function |
US6727197B1 (en) * | 1999-11-18 | 2004-04-27 | Foster-Miller, Inc. | Wearable transmission device |
US20040111040A1 (en) * | 2002-12-04 | 2004-06-10 | Quan Ni | Detection of disordered breathing |
US20040143194A1 (en) * | 2001-03-02 | 2004-07-22 | Norio Kihara | Respiratory function measuring system and application thereof |
US6783498B2 (en) * | 2002-03-26 | 2004-08-31 | Vivometrics, Inc. | Method and system for extracting cardiac parameters from plethysmographic signals |
US6801916B2 (en) * | 1998-04-01 | 2004-10-05 | Cyberpulse, L.L.C. | Method and system for generation of medical reports from data in a hierarchically-organized database |
US20040249299A1 (en) * | 2003-06-06 | 2004-12-09 | Cobb Jeffrey Lane | Methods and systems for analysis of physiological signals |
US20050054941A1 (en) * | 2003-08-22 | 2005-03-10 | Joseph Ting | Physiological monitoring garment |
US20050076908A1 (en) * | 2003-09-18 | 2005-04-14 | Kent Lee | Autonomic arousal detection system and method |
US6881192B1 (en) * | 2002-06-12 | 2005-04-19 | Pacesetter, Inc. | Measurement of sleep apnea duration and evaluation of response therapies using duration metrics |
US20050119586A1 (en) * | 2003-04-10 | 2005-06-02 | Vivometrics, Inc. | Systems and methods for respiratory event detection |
US20050228234A1 (en) * | 2002-05-17 | 2005-10-13 | Chang-Ming Yang | Method and device for monitoring physiologic signs and implementing emergency disposals |
US20050240087A1 (en) * | 2003-11-18 | 2005-10-27 | Vivometrics Inc. | Method and system for processing data from ambulatory physiological monitoring |
US20060017859A1 (en) * | 2004-07-21 | 2006-01-26 | Han-Wook Choi | Image display device having slim type cathode ray tube |
US7081095B2 (en) * | 2001-05-17 | 2006-07-25 | Lynn Lawrence A | Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions |
US7100420B2 (en) * | 2001-06-07 | 2006-09-05 | British American Tobacco (Investments) Limited) | Cigarette monitoring |
US7104962B2 (en) * | 2003-06-24 | 2006-09-12 | Buxco Electronics, Inc. | Cough/sneeze analyzer and method |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5829449A (en) * | 1997-09-19 | 1998-11-03 | Thione International, Inc. | Smoking products containing antioxidants |
JP2001101309A (en) * | 1999-07-28 | 2001-04-13 | Toto Ltd | System for managing living body information |
US7143796B2 (en) | 2002-08-26 | 2006-12-05 | Arasmith Stanley D | Wood-reducing apparatus with continual feeder assembly |
-
2007
- 2007-03-06 US US11/682,601 patent/US20070209669A1/en not_active Abandoned
- 2007-03-07 WO PCT/US2007/005707 patent/WO2007103380A2/en active Application Filing
- 2007-03-07 JP JP2008558358A patent/JP5128505B2/en not_active Expired - Fee Related
- 2007-03-07 CA CA002645027A patent/CA2645027A1/en not_active Abandoned
- 2007-03-07 AU AU2007223995A patent/AU2007223995A1/en not_active Abandoned
- 2007-03-07 EP EP07752409.8A patent/EP1991122B1/en not_active Not-in-force
Patent Citations (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4016868A (en) * | 1975-11-25 | 1977-04-12 | Allison Robert D | Garment for impedance plethysmograph use |
US4815473A (en) * | 1977-04-07 | 1989-03-28 | Respitrace Corporation | Method and apparatus for monitoring respiration |
US4308872A (en) * | 1977-04-07 | 1982-01-05 | Respitrace Corporation | Method and apparatus for monitoring respiration |
US4306567A (en) * | 1977-12-22 | 1981-12-22 | Krasner Jerome L | Detection and monitoring device |
US4273534A (en) * | 1979-08-27 | 1981-06-16 | Sultan Dental Products, Inc. | Amalgam carrier and dispenser |
US4433693A (en) * | 1979-09-27 | 1984-02-28 | Hochstein Peter A | Method and assembly for monitoring respiration and detecting apnea |
US4456015A (en) * | 1981-05-26 | 1984-06-26 | Respitrace Corporation | Non-invasive method for semiquantitative measurement of neck volume changes |
US4597394A (en) * | 1981-05-26 | 1986-07-01 | Respitrace Corporation | Method for noninvasively monitoring mouth volume |
US4452252A (en) * | 1981-05-26 | 1984-06-05 | Respitrace Corporation | Non-invasive method for monitoring cardiopulmonary parameters |
US4463764A (en) * | 1981-09-29 | 1984-08-07 | Medical Graphics Corporation | Cardiopulmonary exercise system |
US4860766A (en) * | 1983-11-18 | 1989-08-29 | Respitrace Corp. | Noninvasive method for measuring and monitoring intrapleural pressure in newborns |
US4966155A (en) * | 1985-01-31 | 1990-10-30 | The University Of Strathclyde | Apparatus for monitoring physiological parameters |
USRE35122E (en) * | 1985-04-01 | 1995-12-19 | Nellcor Incorporated | Method and apparatus for detecting optical pulses |
US4648407A (en) * | 1985-07-08 | 1987-03-10 | Respitrace Corporation | Method for detecting and differentiating central and obstructive apneas in newborns |
US4834109A (en) * | 1986-01-21 | 1989-05-30 | Respitrace Corporation | Single position non-invasive calibration technique |
US4777962A (en) * | 1986-05-09 | 1988-10-18 | Respitrace Corporation | Method and apparatus for distinguishing central obstructive and mixed apneas by external monitoring devices which measure rib cage and abdominal compartmental excursions during respiration |
US4800495A (en) * | 1986-08-18 | 1989-01-24 | Physio-Control Corporation | Method and apparatus for processing signals used in oximetry |
US4807640A (en) * | 1986-11-19 | 1989-02-28 | Respitrace Corporation | Stretchable band-type transducer particularly suited for respiration monitoring apparatus |
US5301678A (en) * | 1986-11-19 | 1994-04-12 | Non-Invasive Monitoring System, Inc. | Stretchable band - type transducer particularly suited for use with respiration monitoring apparatus |
US4753988A (en) * | 1987-02-18 | 1988-06-28 | The Dow Chemical Company | High gloss acrylate rubber-modified weatherable resins |
US4817625A (en) * | 1987-04-24 | 1989-04-04 | Laughton Miles | Self-inductance sensor |
US5007427A (en) * | 1987-05-07 | 1991-04-16 | Capintec, Inc. | Ambulatory physiological evaluation system including cardiac monitoring |
US4796639A (en) * | 1987-11-05 | 1989-01-10 | Medical Graphics Corporation | Pulmonary diagnostic system |
US4834766A (en) * | 1987-11-24 | 1989-05-30 | Sando Iron Works Co., Ltd. | Method for preventing scale adhesion |
US5178151A (en) * | 1988-04-20 | 1993-01-12 | Sackner Marvin A | System for non-invasive detection of changes of cardiac volumes and aortic pulses |
US4972842A (en) * | 1988-06-09 | 1990-11-27 | Vital Signals, Inc. | Method and apparatus for precision monitoring of infants on assisted ventilation |
US5040540A (en) * | 1988-08-24 | 1991-08-20 | Nims, Inc. | Method and apparatus for non-invasive monitoring of central venous pressure, and improved transducer therefor |
US4986277A (en) * | 1988-08-24 | 1991-01-22 | Sackner Marvin A | Method and apparatus for non-invasive monitoring of central venous pressure |
US4960118A (en) * | 1989-05-01 | 1990-10-02 | Pennock Bernard E | Method and apparatus for measuring respiratory flow |
US5074129A (en) * | 1989-12-26 | 1991-12-24 | Novtex | Formable fabric |
US5159935A (en) * | 1990-03-08 | 1992-11-03 | Nims, Inc. | Non-invasive estimation of individual lung function |
US5131399A (en) * | 1990-08-06 | 1992-07-21 | Sciarra Michael J | Patient monitoring apparatus and method |
US5331968A (en) * | 1990-10-19 | 1994-07-26 | Gerald Williams | Inductive plethysmographic transducers and electronic circuitry therefor |
US5749365A (en) * | 1991-11-07 | 1998-05-12 | Magill; Alan | Health monitoring |
US5564429A (en) * | 1991-11-25 | 1996-10-15 | Vitalscan, Inc. | Method of identifying valid signal-carrying channels in a cardiorespiratory alert system |
US5348008A (en) * | 1991-11-25 | 1994-09-20 | Somnus Corporation | Cardiorespiratory alert system |
US5353793A (en) * | 1991-11-25 | 1994-10-11 | Oishi-Kogyo Company | Sensor apparatus |
US5899855A (en) * | 1992-11-17 | 1999-05-04 | Health Hero Network, Inc. | Modular microprocessor-based health monitoring system |
US5588425A (en) * | 1993-05-21 | 1996-12-31 | Nims, Incorporated | Method and apparatus for discriminating between valid and artifactual pulse waveforms in pulse oximetry |
US5447164A (en) * | 1993-11-08 | 1995-09-05 | Hewlett-Packard Company | Interactive medical information display system and method for displaying user-definable patient events |
US5533511A (en) * | 1994-01-05 | 1996-07-09 | Vital Insite, Incorporated | Apparatus and method for noninvasive blood pressure measurement |
US5544661A (en) * | 1994-01-13 | 1996-08-13 | Charles L. Davis | Real time ambulatory patient monitor |
US5416961A (en) * | 1994-01-26 | 1995-05-23 | Schlegel Corporation | Knitted wire carrier having bonded warp threads and method for forming same |
US5601088A (en) * | 1995-02-17 | 1997-02-11 | Ep Technologies, Inc. | Systems and methods for filtering artifacts from composite signals |
US6066093A (en) * | 1995-07-28 | 2000-05-23 | Unilead International Inc. | Disposable electrodeless electro-dermal devices |
US5577510A (en) * | 1995-08-18 | 1996-11-26 | Chittum; William R. | Portable and programmable biofeedback system with switching circuit for voice-message recording and playback |
US5694939A (en) * | 1995-10-03 | 1997-12-09 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Autogenic-feedback training exercise (AFTE) method and system |
US5820567A (en) * | 1995-11-02 | 1998-10-13 | Healthcare Technology Limited | Heart rate sensing apparatus adapted for chest or earlobe mounted sensor |
US6261238B1 (en) * | 1996-10-04 | 2001-07-17 | Karmel Medical Acoustic Technologies, Ltd. | Phonopneumograph system |
US6068568A (en) * | 1996-12-12 | 2000-05-30 | Tsubakimoto Chain Co. | Silent chain |
US5991922A (en) * | 1996-12-26 | 1999-11-30 | Banks; David L. | Monitored static electricity dissipation garment |
US6511424B1 (en) * | 1997-01-11 | 2003-01-28 | Circadian Technologies, Inc. | Method of and apparatus for evaluation and mitigation of microsleep events |
US6070098A (en) * | 1997-01-11 | 2000-05-30 | Circadian Technologies, Inc. | Method of and apparatus for evaluation and mitigation of microsleep events |
US6015388A (en) * | 1997-03-17 | 2000-01-18 | Nims, Inc. | Method for analyzing breath waveforms as to their neuromuscular respiratory implications |
US6047203A (en) * | 1997-03-17 | 2000-04-04 | Nims, Inc. | Physiologic signs feedback system |
US6067462A (en) * | 1997-04-14 | 2000-05-23 | Masimo Corporation | Signal processing apparatus and method |
US5913830A (en) * | 1997-08-20 | 1999-06-22 | Respironics, Inc. | Respiratory inductive plethysmography sensor |
US6254552B1 (en) * | 1997-10-03 | 2001-07-03 | E.I. Du Pont De Nemours And Company | Intra-coronary radiation devices containing Ce-144 or Ru-106 |
US6579231B1 (en) * | 1998-03-27 | 2003-06-17 | Mci Communications Corporation | Personal medical monitoring unit and system |
US6801916B2 (en) * | 1998-04-01 | 2004-10-05 | Cyberpulse, L.L.C. | Method and system for generation of medical reports from data in a hierarchically-organized database |
US6302844B1 (en) * | 1999-03-31 | 2001-10-16 | Walker Digital, Llc | Patient care delivery system |
US6436057B1 (en) * | 1999-04-22 | 2002-08-20 | The United States Of America As Represented By The Department Of Health And Human Services, Centers For Disease Control And Prevention | Method and apparatus for cough sound analysis |
US6723055B2 (en) * | 1999-04-23 | 2004-04-20 | Trustees Of Tufts College | System for measuring respiratory function |
US6656127B1 (en) * | 1999-06-08 | 2003-12-02 | Oridion Breathid Ltd. | Breath test apparatus and methods |
US6223072B1 (en) * | 1999-06-08 | 2001-04-24 | Impulse Dynamics N.V. | Apparatus and method for collecting data useful for determining the parameters of an alert window for timing delivery of ETC signals to a heart under varying cardiac conditions |
US6413225B1 (en) * | 1999-06-18 | 2002-07-02 | Vivometrics, Inc. | Quantitative calibration of breathing monitors with transducers placed on both rib cage and abdomen |
US6142953A (en) * | 1999-07-08 | 2000-11-07 | Compumedics Sleep Pty Ltd | Respiratory inductive plethysmography band transducer |
US6449504B1 (en) * | 1999-08-20 | 2002-09-10 | Cardiac Pacemakers, Inc. | Arrhythmia display |
US6721594B2 (en) * | 1999-08-24 | 2004-04-13 | Cardiac Pacemakers, Inc. | Arrythmia display |
US6604115B1 (en) * | 1999-11-05 | 2003-08-05 | Ge Marquette Medical Systems, Inc. | Method and apparatus for storing data |
US6727197B1 (en) * | 1999-11-18 | 2004-04-27 | Foster-Miller, Inc. | Wearable transmission device |
US20030135127A1 (en) * | 2000-04-17 | 2003-07-17 | Vivometrics, Inc. | Systems and methods for ambulatory monitoring of physiological signs |
US6551252B2 (en) * | 2000-04-17 | 2003-04-22 | Vivometrics, Inc. | Systems and methods for ambulatory monitoring of physiological signs |
US6633772B2 (en) * | 2000-08-18 | 2003-10-14 | Cygnus, Inc. | Formulation and manipulation of databases of analyte and associated values |
US6341504B1 (en) * | 2001-01-31 | 2002-01-29 | Vivometrics, Inc. | Composite elastic and wire fabric for physiological monitoring apparel |
US20040143194A1 (en) * | 2001-03-02 | 2004-07-22 | Norio Kihara | Respiratory function measuring system and application thereof |
US7081095B2 (en) * | 2001-05-17 | 2006-07-25 | Lynn Lawrence A | Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions |
US7100420B2 (en) * | 2001-06-07 | 2006-09-05 | British American Tobacco (Investments) Limited) | Cigarette monitoring |
US6783498B2 (en) * | 2002-03-26 | 2004-08-31 | Vivometrics, Inc. | Method and system for extracting cardiac parameters from plethysmographic signals |
US20060036183A1 (en) * | 2002-03-26 | 2006-02-16 | Vivometrics Inc. | Method and system for extracting cardiac parameters from plethysmographic signals |
US20050228234A1 (en) * | 2002-05-17 | 2005-10-13 | Chang-Ming Yang | Method and device for monitoring physiologic signs and implementing emergency disposals |
US6881192B1 (en) * | 2002-06-12 | 2005-04-19 | Pacesetter, Inc. | Measurement of sleep apnea duration and evaluation of response therapies using duration metrics |
US20040030508A1 (en) * | 2002-08-08 | 2004-02-12 | Likness Mark A. | Method for measuring smoking topography |
US7164993B2 (en) * | 2002-08-08 | 2007-01-16 | Plowshare Technologies, Inc. | Method for measuring smoking topography |
US20040111040A1 (en) * | 2002-12-04 | 2004-06-10 | Quan Ni | Detection of disordered breathing |
US20050119586A1 (en) * | 2003-04-10 | 2005-06-02 | Vivometrics, Inc. | Systems and methods for respiratory event detection |
US20040249299A1 (en) * | 2003-06-06 | 2004-12-09 | Cobb Jeffrey Lane | Methods and systems for analysis of physiological signals |
US7104962B2 (en) * | 2003-06-24 | 2006-09-12 | Buxco Electronics, Inc. | Cough/sneeze analyzer and method |
US20050054941A1 (en) * | 2003-08-22 | 2005-03-10 | Joseph Ting | Physiological monitoring garment |
US20050076908A1 (en) * | 2003-09-18 | 2005-04-14 | Kent Lee | Autonomic arousal detection system and method |
US20050240087A1 (en) * | 2003-11-18 | 2005-10-27 | Vivometrics Inc. | Method and system for processing data from ambulatory physiological monitoring |
US20060017859A1 (en) * | 2004-07-21 | 2006-01-26 | Han-Wook Choi | Image display device having slim type cathode ray tube |
Cited By (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9462975B2 (en) | 1997-03-17 | 2016-10-11 | Adidas Ag | Systems and methods for ambulatory monitoring of physiological signs |
US9750429B1 (en) | 2000-04-17 | 2017-09-05 | Adidas Ag | Systems and methods for ambulatory monitoring of physiological signs |
US10478065B2 (en) | 2004-06-18 | 2019-11-19 | Adidas Ag | Systems and methods for monitoring subjects in potential physiological distress |
US9492084B2 (en) | 2004-06-18 | 2016-11-15 | Adidas Ag | Systems and methods for monitoring subjects in potential physiological distress |
US8628480B2 (en) | 2005-05-20 | 2014-01-14 | Adidas Ag | Methods and systems for monitoring respiratory data |
US8033996B2 (en) | 2005-07-26 | 2011-10-11 | Adidas Ag | Computer interfaces including physiologically guided avatars |
US8790255B2 (en) | 2005-07-26 | 2014-07-29 | Adidas Ag | Computer interfaces including physiologically guided avatars |
US9504410B2 (en) | 2005-09-21 | 2016-11-29 | Adidas Ag | Band-like garment for physiological monitoring |
US8762733B2 (en) | 2006-01-30 | 2014-06-24 | Adidas Ag | System and method for identity confirmation using physiologic biometrics to determine a physiologic fingerprint |
US8475387B2 (en) | 2006-06-20 | 2013-07-02 | Adidas Ag | Automatic and ambulatory monitoring of congestive heart failure patients |
US9833184B2 (en) | 2006-10-27 | 2017-12-05 | Adidas Ag | Identification of emotional states using physiological responses |
US20080211640A1 (en) * | 2007-01-10 | 2008-09-04 | Halo Monitoring, Inc. | Wireless Sensor Network Data Management System and Method |
US20080211657A1 (en) * | 2007-01-10 | 2008-09-04 | Halo Monitoring, Inc. | Wireless Sensor Network Calibration System and Method |
US8556833B2 (en) | 2007-01-10 | 2013-10-15 | Integrity Tracking, Llc | Wireless sensor network system and method |
US20080164979A1 (en) * | 2007-01-10 | 2008-07-10 | Halo Monitoring, Inc. | Wireless Sensor Network System and Method |
US20080164999A1 (en) * | 2007-01-10 | 2008-07-10 | Halo Monitoring, Inc. | Wireless Sensor Network Context Data Delivery System and Method |
US7843325B2 (en) | 2007-01-10 | 2010-11-30 | Halo Monitoring, Inc. | Wireless sensor network context data delivery system and method |
US8253547B2 (en) | 2007-01-10 | 2012-08-28 | Halo Monitoring, Inc. | Wireless sensor network data management system and method |
US8912899B2 (en) | 2007-01-10 | 2014-12-16 | Integrity Tracking, Llc | Wireless sensor network calibration system and method |
US9295412B2 (en) | 2007-08-15 | 2016-03-29 | Integrity Tracking, Llc | Wearable health monitoring device and methods for step detection |
US9179864B2 (en) | 2007-08-15 | 2015-11-10 | Integrity Tracking, Llc | Wearable health monitoring device and methods for fall detection |
US20090069724A1 (en) * | 2007-08-15 | 2009-03-12 | Otto Chris A | Wearable Health Monitoring Device and Methods for Step Detection |
US20090048540A1 (en) * | 2007-08-15 | 2009-02-19 | Otto Chris A | Wearable Health Monitoring Device and Methods for Fall Detection |
US20100305958A1 (en) * | 2007-11-30 | 2010-12-02 | Japan Tobacco, Inc. | Data processing system, computer program used therefor, and data processing method |
US20100312570A1 (en) * | 2007-11-30 | 2010-12-09 | Hisaaki Shimo | Data processing system |
US20150065825A1 (en) * | 2009-10-24 | 2015-03-05 | David Scott Utley | Extracorporeal Devices and Methods for Facilitating Cessation of Undesired Behaviors |
US11653878B2 (en) | 2009-10-24 | 2023-05-23 | Pivot Health Technologies Inc. | Systems and methods for quantification of, and prediction of smoking behavior |
US9420971B2 (en) * | 2009-10-24 | 2016-08-23 | Carrot Sense, Inc. | Extracorporeal devices and methods for facilitating cessation of undesired behaviors |
US9675275B2 (en) | 2009-10-24 | 2017-06-13 | Carrot Sense, Inc. | Extracorporeal devices and methods for facilitating cessation of undesired behaviors |
WO2011131235A1 (en) * | 2010-04-20 | 2011-10-27 | Wearable Information Technologies, S.L. (Weartech) | Monitoring system |
US8868616B1 (en) | 2011-07-07 | 2014-10-21 | Integrity Tracking, Llc | Event data monitoring systems and methods |
WO2015026000A1 (en) * | 2013-08-23 | 2015-02-26 | 케이티메드 주식회사 | Health education apparatus |
US10034500B2 (en) * | 2013-10-25 | 2018-07-31 | Seiko Instruments Inc. | Garment |
US20150119675A1 (en) * | 2013-10-25 | 2015-04-30 | Seiko Instruments Inc. | Garment |
CN104970442A (en) * | 2014-04-03 | 2015-10-14 | 惠州市吉瑞科技有限公司 | Information interaction method and system |
US9861126B2 (en) | 2015-04-07 | 2018-01-09 | Carrot, Inc. | Systems and methods for quantification of, and prediction of smoking behavior |
US11412784B2 (en) | 2015-04-07 | 2022-08-16 | Pivot Health Technologies Inc. | Systems and methods for quantification of, and prediction of smoking behavior |
US10306922B2 (en) | 2015-04-07 | 2019-06-04 | Carrot, Inc. | Systems and methods for quantification of, and prediction of smoking behavior |
US10674761B2 (en) | 2015-04-07 | 2020-06-09 | Carrot, Inc. | Systems and methods for quantification of, and prediction of smoking behavior |
US11723579B2 (en) | 2017-09-19 | 2023-08-15 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement |
US11278203B2 (en) | 2017-10-10 | 2022-03-22 | Carrot, Inc. | Systems and methods for quantification of, and prediction of smoking behavior |
US10674913B2 (en) | 2017-10-10 | 2020-06-09 | Carrot, Inc. | Systems and methods for quantification of, and prediction of smoking behavior |
US10206572B1 (en) | 2017-10-10 | 2019-02-19 | Carrot, Inc. | Systems and methods for quantification of, and prediction of smoking behavior |
US10335032B2 (en) | 2017-10-10 | 2019-07-02 | Carrot, Inc. | Systems and methods for quantification of, and prediction of smoking behavior |
US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
US20200303058A1 (en) * | 2017-12-18 | 2020-09-24 | Omron Corporation | Lifestyle habit management device, method, and non-transitory recording medium in which program is stored |
US11273283B2 (en) | 2017-12-31 | 2022-03-15 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
US11318277B2 (en) | 2017-12-31 | 2022-05-03 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
US11478603B2 (en) | 2017-12-31 | 2022-10-25 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
US11452839B2 (en) | 2018-09-14 | 2022-09-27 | Neuroenhancement Lab, LLC | System and method of improving sleep |
CN111134365A (en) * | 2018-11-02 | 2020-05-12 | 日本烟草产业株式会社 | Smoke supply device and personal health state evaluation system |
US11786694B2 (en) | 2019-05-24 | 2023-10-17 | NeuroLight, Inc. | Device, method, and app for facilitating sleep |
US11568980B2 (en) | 2019-12-30 | 2023-01-31 | Pivot Health Technologies Inc. | Systems and methods for assisting individuals in a behavioral-change program |
US11257583B2 (en) | 2019-12-30 | 2022-02-22 | Carrot, Inc. | Systems and methods for assisting individuals in a behavioral-change program |
Also Published As
Publication number | Publication date |
---|---|
JP2009529730A (en) | 2009-08-20 |
AU2007223995A1 (en) | 2007-09-13 |
JP5128505B2 (en) | 2013-01-23 |
WO2007103380A2 (en) | 2007-09-13 |
EP1991122A4 (en) | 2010-03-31 |
CA2645027A1 (en) | 2007-09-13 |
EP1991122B1 (en) | 2017-04-19 |
EP1991122A2 (en) | 2008-11-19 |
WO2007103380A3 (en) | 2008-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1991122B1 (en) | Monitoring and quantification of smoking behaviors | |
CA2606699C (en) | Methods and systems for determining dynamic hyperinflation | |
US7678061B2 (en) | System and method for characterizing patient respiration | |
US9833184B2 (en) | Identification of emotional states using physiological responses | |
Sazonov et al. | A wearable sensor system for monitoring cigarette smoking | |
US8323204B2 (en) | Medical event logbook system and method | |
US20200260962A1 (en) | System and methods for acquisition and analysis of health data | |
JP7393405B2 (en) | Systems and methods for screening, diagnosing and monitoring sleep-disordered breathing | |
CN105792733A (en) | Sleep monitoring device | |
CN1713850B (en) | Apparatus for maintaining and monitoring sleep quality during therapeutic treatments | |
US11793453B2 (en) | Detecting and measuring snoring | |
CN111166336B (en) | Device and method for detecting and monitoring cough | |
Lorig et al. | The effects of active and passive stimulation on chemosensory event-related potentials | |
CN110459291A (en) | Aiding smoking cessation small watersheds and method based on mobile intelligent terminal | |
Belsare et al. | Computation of Cigarette Smoke Exposure Metrics from Breathing | |
Patil et al. | Detection of cigarette smoke inhalations from respiratory signals using reduced feature set | |
CN108283490A (en) | Sleep-respiratory system and method | |
Belsare et al. | Analyzing Impact of Mouthpiece-based Puff Topography Devices on Smoking Behavior using Wearable Sensors | |
Imtiaz | Wearable sensor systems to study the physiological and behavioral manifestation of cigarette smoking in free-living | |
Lin | A novel device to measure long-term oxygen therapy use: Design and application for identifying adherence patterns |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: VIVOMETRICS, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DERCHAK, P. ALEXANDER;REEL/FRAME:019093/0679 Effective date: 20070228 |
|
AS | Assignment |
Owner name: ADIDAS AG,GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:TEXTRONICS, INC.;REEL/FRAME:024474/0783 Effective date: 20100526 Owner name: ADIDAS AG, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:TEXTRONICS, INC.;REEL/FRAME:024474/0783 Effective date: 20100526 |
|
AS | Assignment |
Owner name: TEXTRONICS, INC. D/B/A ADIDAS WEARABLE SPORTS ELEC Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VIVOMETRICS, INC.;REEL/FRAME:024483/0216 Effective date: 20100430 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |